ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging).

PubWeight™: 2.88‹?› | Rank: Top 1%

🔗 View Article (PMID 14522503)

Published in J Am Coll Cardiol on October 01, 2003

Authors

Francis J Klocke, Michael G Baird, Beverly H Lorell, Timothy M Bateman, Joseph V Messer, Daniel S Berman, Patrick T O'Gara, Blase A Carabello, Richard O Russell, Manuel D Cerqueira, Martin G St John Sutton, Anthony N DeMaria, James E Udelson, J Ward Kennedy, Mario S Verani, Kim Allan Williams, Elliott M Antman, Sidney C Smith, Joseph S Alpert, Gabriel Gregoratos, Jeffrey L Anderson, Loren F Hiratzka, David P Faxon, Sharon Ann Hunt, Valentin Fuster, Alice K Jacobs, Raymond J Gibbons, Richard O Russell, American College of Cardiology, American Heart Association, American Society for Nuclear Cardiology

Associated clinical trials:

Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain | NCT00678639

Randomized Investigation of Chest Pain Diagnostic Strategies | NCT01035047

Articles citing this

(truncated to the top 100)

Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38

The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg (2007) 3.45

Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging (2004) 2.41

Detection of myocardial damage in patients with sarcoidosis. Circulation (2009) 2.31

Effects of radiation exposure from cardiac imaging: how good are the data? J Am Coll Cardiol (2012) 2.15

Left ventricular ejection fraction measurements: accuracy and prognostic implications in a large population of patients with known or suspected ischemic heart disease. Int J Cardiovasc Imaging (2008) 2.06

Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC). Eur J Nucl Med Mol Imaging (2011) 1.96

Comparison of long-term mortality risk following normal exercise vs adenosine myocardial perfusion SPECT. J Nucl Cardiol (2010) 1.71

(13)N-ammonia myocardial perfusion imaging with a PET/CT scanner: impact on clinical decision making and cost-effectiveness. Eur J Nucl Med Mol Imaging (2007) 1.46

Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Soc Echocardiogr (2009) 1.45

The regulatory background of nuclear cardiology in Europe: a survey by the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging (2006) 1.39

Comparison of the sensitivity and specificity of 5 image sets of dual-energy computed tomography for detecting first-pass myocardial perfusion defects compared with positron emission tomography. Medicine (Baltimore) (2014) 1.38

Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Proc Natl Acad Sci U S A (2011) 1.29

EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging (2008) 1.29

Downstream procedures and outcomes after stress testing for chest pain without known coronary artery disease in the United States. Am Heart J (2012) 1.20

¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging (2011) 1.15

Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues. Circulation (2012) 1.14

Myocardial scars determined by delayed-enhancement magnetic resonance imaging and positron emission tomography are not common in right ventricles with systemic function in long-term follow up. Heart (2006) 1.04

Signal density of left ventricular myocardial segments and impact of beam hardening artifact: implications for myocardial perfusion assessment by multidetector CT coronary angiography. Int J Cardiovasc Imaging (2009) 1.02

Chronic coronary artery disease: diagnosis and management. Mayo Clin Proc (2009) 1.00

The underuse of overuse research. Health Serv Res (2008) 1.00

PET and MRI in cardiac imaging: from validation studies to integrated applications. Eur J Nucl Med Mol Imaging (2009) 1.00

Integration of coronary anatomy and myocardial perfusion imaging. Nat Rev Cardiol (2010) 1.00

Accuracy of 64-slice CT angiography for the detection of functionally relevant coronary stenoses as assessed with myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging (2007) 1.00

CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease--executive summary. Can J Cardiol (2007) 0.99

Recent developments in non-invasive cardiology. BMJ (2004) 0.99

Evaluation of ischaemia in obese patients: feasibility and accuracy of a low-dose protocol with a cadmium-zinc telluride camera. Eur J Nucl Med Mol Imaging (2012) 0.99

Incremental value of dual-energy CT to coronary CT angiography for the detection of significant coronary stenosis: comparison with quantitative coronary angiography and single photon emission computed tomography. Int J Cardiovasc Imaging (2011) 0.95

Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis (2009) 0.94

Prognostic utility of sestamibi lung uptake does not require adjustment for stress-related variables: a retrospective cohort study. BMC Nucl Med (2006) 0.90

PET/MR: a paradigm shift. Cancer Imaging (2013) 0.90

Detection of non-ST-elevation myocardial infarction and unstable angina in the acute setting: meta-analysis of diagnostic performance of multi-detector computed tomographic angiography. BMC Cardiovasc Disord (2007) 0.90

The future of hybrid imaging-part 1: hybrid imaging technologies and SPECT/CT. Insights Imaging (2011) 0.90

Non-invasive imaging in coronary artery disease including anatomical and functional evaluation of ischaemia and viability assessment. Br J Radiol (2011) 0.88

High probability of disease in angina pectoris patients: is clinical estimation reliable? Can J Cardiol (2007) 0.88

Diagnostic accuracy of myocardial perfusion imaging with single photon emission computed tomography and positron emission tomography: a comparison with coronary angiography. Int J Cardiovasc Imaging (2007) 0.88

Cardiac PET perfusion: prognosis, risk stratification, and clinical management. Semin Nucl Med (2014) 0.87

New methods for improved evaluation of patients with suspected acute coronary syndrome in the emergency department. Emerg Med J (2007) 0.86

Diagnostic and prognostic value of non-invasive imaging in known or suspected coronary artery disease. Eur J Nucl Med Mol Imaging (2006) 0.86

Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD. Kidney Int Suppl (2011) (2013) 0.86

Mechanisms of arrhythmias and conduction disorders in older adults. Clin Geriatr Med (2012) 0.85

Diagnostic value of (18)F-FDG PET in the assessment of myocardial viability in coronary artery disease: A comparative study with (99m)Tc SPECT and echocardiography. J Geriatr Cardiol (2014) 0.85

New reconstruction algorithm allows shortened acquisition time for myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging (2009) 0.84

Non-invasive assessment of coronary artery disease with CT coronary angiography and SPECT: a novel dose-saving fast-track algorithm. Eur J Nucl Med Mol Imaging (2009) 0.83

Development of a theory for generating regional cardiac perfusion images during coronary angiography in the coronary angiography lab. Int J Cardiovasc Imaging (2013) 0.83

Comparison of traditional cardiovascular risk models and coronary atherosclerotic plaque as detected by computed tomography for prediction of acute coronary syndrome in patients with acute chest pain. Acad Emerg Med (2012) 0.82

Integrated assessment of coronary anatomy and myocardial perfusion using a retractable SPECT camera combined with 64-slice CT: initial experience. Eur Radiol (2008) 0.82

Review of Movahed's sign (D shaped left ventricle seen on gated SPECT) suggestive of right ventricular overload. Int J Cardiovasc Imaging (2010) 0.82

Chapter 5: Referral to specialists and models of care. Kidney Int Suppl (2011) (2013) 0.82

Higher events rate in patients with a normal gated myocardial perfusion imaging with dipyridamole than exercise: "Run for reliability". Indian J Nucl Med (2012) 0.82

Correlation of myocardial perfusion SPECT with invasive and computed tomography coronary angiogram. Indian Heart J (2012) 0.81

Cost-effectiveness of different diagnostic strategies in suspected stable coronary artery disease in Portugal. Arq Bras Cardiol (2014) 0.81

Comparison of radionuclide ventriculography using SPECT and planar techniques in different cardiac conditions. Eur J Nucl Med Mol Imaging (2007) 0.80

Prognosis in patients achieving ≥10 METS on exercise stress testing: was SPECT imaging useful? J Nucl Cardiol (2010) 0.80

Investigation route of the coronary patient in the public health system in Curitiba, São Paulo and in InCor--IMPACT study. Arq Bras Cardiol (2014) 0.79

64-slice CT angiography for the detection of functionally significant coronary stenoses: comparison with stress myocardial perfusion imaging. Br J Radiol (2011) 0.79

Comparison of computed tomographic angiography versus rubidium-82 positron emission tomography for the detection of patients with anatomical coronary artery disease. Can J Cardiol (2007) 0.78

Cardiac hybrid imaging. Eur J Nucl Med Mol Imaging (2014) 0.78

Contemporary relevance of TID: Based on the company it keeps. J Nucl Cardiol (2015) 0.78

Factors associated with false-negative cardiovascular magnetic resonance perfusion studies: A Clinical evaluation of magnetic resonance imaging in coronary artery disease (CE-MARC) substudy. J Magn Reson Imaging (2015) 0.78

Multi-modality imaging for the assessment of myocardial perfusion with emphasis on stress perfusion CT and MR imaging. Int J Cardiovasc Imaging (2015) 0.78

Myocardial blood flow quantification for evaluation of coronary artery disease by positron emission tomography, cardiac magnetic resonance imaging, and computed tomography. Curr Cardiol Rep (2014) 0.78

Myocardial perfusion imaging and infarct characterization using multidetector cardiac computed tomography. World J Cardiol (2010) 0.78

Gender differences in myocardial perfusion defect in asymptomatic postmenopausal women and men with and without diabetes mellitus. J Womens Health (Larchmt) (2013) 0.77

Utility of both carotid intima-media thickness and endothelial function for cardiovascular risk stratification in patients with angina-like symptoms. Int J Cardiol (2015) 0.77

Radionuclide imaging in risk assessment after acute coronary syndromes. Heart (2004) 0.77

Negative predictive value and potential cost savings of acute nuclear myocardial perfusion imaging in low risk patients with suspected acute coronary syndrome: a prospective single blinded study. BMC Emerg Med (2009) 0.76

Advanced tracers in PET imaging of cardiovascular disease. Biomed Res Int (2014) 0.76

Medical history for prognostic risk assessment and diagnosis of stable patients with suspected coronary artery disease. Am J Med (2015) 0.76

Prognostic value of stress 99mTc-tetrofosmin myocardial perfusion imaging in predicting all-cause mortality: a 6-year follow-up study. Eur J Nucl Med Mol Imaging (2006) 0.76

Clinical Role of Hybrid Imaging. Curr Cardiovasc Imaging Rep (2010) 0.76

Stress-induced abnormalities in myocardial perfusion imaging that are not related to perfusion but are of diagnostic and prognostic importance. Eur J Nucl Med Mol Imaging (2006) 0.76

Prognosis of normal stress-only gated-SPECT myocardial perfusion imaging: a single center study. Int J Cardiovasc Imaging (2013) 0.76

Re: applicability, limitations and downstream impact of echocardiography utilization based on the Appropriateness Use Criteria for transthoracic and transesophageal echocardiography. Int J Cardiovasc Imaging (2012) 0.75

Diagnostic Strategies for Early Recognition of Cancer Therapeutics-Related Cardiac Dysfunction. Clin Med Insights Cardiol (2017) 0.75

MDCT is better than stress perfusion imaging for detecting CAD--Against. Eur J Nucl Med Mol Imaging (2006) 0.75

Myeloperoxidase is not useful for detecting stress inducible myocardial ischemia but may be indicative of the severity of coronary artery disease. Korean Circ J (2014) 0.75

Noninvasive imaging in coronary artery disease. Semin Nucl Med (2014) 0.75

Rationale and Design of the CREDENCE Trial: computed TomogRaphic evaluation of atherosclerotic DEtermiNants of myocardial IsChEmia. BMC Cardiovasc Disord (2016) 0.75

Imaging techniques in acute coronary syndromes: a review. ISRN Cardiol (2011) 0.75

Aortic pulse wave velocity and its relationship with complexity of coronary artery disease based on SYNTAX score. Heart Asia (2014) 0.75

An empirical method for reducing variability and complexity of myocardial perfusion quantification by dual bolus cardiac MRI. Magn Reson Med (2016) 0.75

Additive Value of B-Type Natriuretic Peptide on Rest Tl-Dipyridamole Stress Tc-Sestamibi Gated Myocardial SPECT in Patients with Normal Left Ventricular Systolic Function. Cardiol Res Pract (2010) 0.75

Myocardial arterial spin labeling. J Cardiovasc Magn Reson (2016) 0.75

Variation in heart rate influences the assessment of transient ischemic dilation in myocardial perfusion scintigraphy. BMC Nucl Med (2007) 0.75

The Big Picture: Evidence Base and Current Trials in Cardiac CT. Curr Radiol Rep (2013) 0.75

Prognostic value of treadmill exercise and dobutamine stress positron emission tomography. Can J Cardiol (2009) 0.75

Performance of Myocardial Perfusion Imaging Using Multi-focus Fan Beam Collimator with Resolution Recovery Reconstruction in a Comparison with Conventional SPECT. Asia Ocean J Nucl Med Biol (2014) 0.75

Multimodality imaging in the evaluation of cardiovascular manifestations of malignancy. Cardiol Res Pract (2011) 0.75

Assessment of prognosis in chronic coronary artery disease. Heart (2004) 0.75

Myocardial perfusion imaging and cardiovascular outcomes in a cancer population. Tex Heart Inst J (2009) 0.75

Incremental value of PET and MRI in the evaluation of cardiovascular abnormalities. Insights Imaging (2016) 0.75

Cost-effectiveness of diagnostic evaluation strategies for individuals with stable chest pain syndrome and suspected coronary artery disease. Clin Imaging (2017) 0.75

Perioperative evaluation of cardiac surgical risk: particularities in the emergency surgery - from the guidelines to the clinical practice. J Med Life (2013) 0.75

Stress myocardial perfusion imaging in the emergency department--new techniques for speed and diagnostic accuracy. Curr Cardiol Rev (2012) 0.75

New insights from major prospective cohort studies with cardiac CT. Curr Cardiol Rep (2015) 0.75

Diagnostic accuracy of an artificial neural network compared with statistical quantitation of myocardial perfusion images: a Japanese multicenter study. Eur J Nucl Med Mol Imaging (2017) 0.75

Hypodense regions in unenhanced CT identify nonviable myocardium: validation versus 18F-FDG PET. Eur J Nucl Med Mol Imaging (2012) 0.75

Diagnostic pathway of integrated SPECT/CT for coronary artery disease. Eur J Nucl Med Mol Imaging (2009) 0.75

Impact of Follow-Up Ischemia on Myocardial Perfusion Single-Photon Emission Computed Tomography in Patients with Coronary Artery Disease. Yonsei Med J (2017) 0.75

Articles by these authors

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation (2009) 35.24

Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation (2003) 23.97

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation (2004) 23.07

Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation (2002) 21.38

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation (2004) 20.67

Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation (2010) 19.30

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation (2005) 18.90

Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation (2007) 18.32

Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2007) 17.85

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 16.52

Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA (2009) 13.69

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation (2006) 13.21

Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation (2004) 13.07

Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke (2007) 12.77

Universal definition of myocardial infarction. Circulation (2007) 11.69

ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation (2006) 11.49

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation (2004) 11.41

Recommendations for chamber quantification. Eur J Echocardiogr (2006) 11.39

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation (2005) 10.98

Strategies for multivessel revascularization in patients with diabetes. N Engl J Med (2012) 10.79

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol (2007) 10.19

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA (2004) 9.91

ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation (2006) 9.83

Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation (2006) 9.44

Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med (2008) 9.25

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation (2010) 9.07

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation (2002) 9.04

Universal definition of myocardial infarction. Eur Heart J (2007) 9.04

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation (2008) 8.94

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation (2009) 8.93

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90

Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med (2015) 8.70

Universal definition of myocardial infarction. J Am Coll Cardiol (2007) 8.68

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61

Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation (2005) 8.59

Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59

Third universal definition of myocardial infarction. Circulation (2012) 8.47